| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| ALBENDAZOLE (has an active metabolite)
| ALBENDAZOLE | ANTIPARASITIC | ORAL | SOLUBILITY PRACTICALLY INSOLUBLE IN WATER | TUBULIN | TUBULIN INHIBITOR CHEMBL2364704 TUBULIN C4PKY4 BETA-TUBULIN ISOFORM 1 TAENIIDAE STRUCTURAL | EMA | |||
| 2 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| M ALBENDAZOLE (is an active metabolite)
| ALBENDAZOLE | ANTIPARASITIC | - | Cmax 4.66 MICROMOLAR Tmax 3.5 HOUR F 5 PERCENT PPB 70 PERCENT HT 10 HOUR | TUBULIN | TUBULIN INHIBITOR CHEMBL2364704 TUBULIN C4PKY4 BETA-TUBULIN ISOFORM 1 TAENIIDAE STRUCTURAL | EMA | |||
